Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 2/3
This trial is looking at a drug called pumitamig in combination with .
It is for people whose non small cell lung cancer has spread and they:
are having their first treatment for non small cell lung cancer
can’t have surgery or radiotherapy with the aim to cure
You pronounce pumitamig as puh-mih-tah-mig.
Recruitment start: 28 February 2025
Recruitment end: 1 August 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Yvonne Summers
BioNTech SE
Last reviewed: 12 Mar 2026
CRUK internal database number: 20018
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
